| This week's sponsor is Premier Research. | |  | Overcoming Risk in Oncology Drug Development
Oncology drug development is fraught with obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Monday, May 6, 2019 Lundbeck is set to pay $250 million (€223 million) upfront to buy Abide Therapeutics. The deal will give Lundbeck a phase 2a Tourette's syndrome program, a CNS drug discovery platform and a West Coast research hub. |
|
|
Top Stories Monday, May 6, 2019 Cytokinetics’ reldesemtiv has missed the primary endpoint in a phase 2 amyotrophic lateral sclerosis trial. The Astellas-partnered drug failed to beat placebo on a lung function test, but Cytokinetics thinks a post hoc analysis shows a path forward for the program. Monday, May 6, 2019 RNA biotech Skyhawk Therapeutics is inking another R&D deal—this time, it’s with Takeda, which wants to use the biotech’s platform to develop small molecules that correct RNA mis-splicing in neurodegenerative disease. Monday, May 6, 2019 Drug discovery biotech FogPharma has hired Howard Stern, M.D., Ph.D., who led translational work at Juno Therapeutics, as its new chief scientific officer, and Peter Fekkes, Ph.D., as vice president of discovery bioscience. Monday, May 6, 2019 It’s not often that biotech sees a record-breaking IPO, but longtime unicorn and fundraising champ Moderna managed just that last year. And the newly public company’s CEO, Stéphane Bancel, topped the charts himself with a $58.6 million compensation package. Resources Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Elemental Machines Learn how cloud-connected IoT sensors are transforming operations in leading life science labs. Read our white paper “The Smart Lab”. Presented by: Total Brain Total Brain Announces Personalized Test for Treatment Prediction in Depression with 80% Accuracy. Sponsored by: Veradigm Prescription price transparency technology is here – but is it making a difference? Find out HERE. Sponsored by: Strativity Every life sciences firm talks about patient-centricity, but are you doing what it takes to deliver? Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
